The productivity of research and development in the bio-pharmaceutical industry has been constantly declining since the early 2000's. One possible reason is that biomedical projects are risky, take a long time, and require significant investment. Hence, substantial capital has been shifted away from the bio-pharmaceutical industry to other industries that are perceived less risky, creating a fu...
